Inosine monophosphate dehydrogenase activity as a biomarker of mycophemolic acid effects in pediatric kidney transplant recipients.

被引：0
|
作者：
Thogersen, H. [1 ]
Goebel, J. [2 ]
Cox, S. [3 ]
Maseck, D. [3 ]
Logan, B. [2 ]
Vinks, A. A. [3 ]
机构：
[1] Univ Oslo, Oslo, Norway
[2] Dept Nephrol, Cincinnati, OH USA
[3] Childrens Hosp Med Ctr, Cincinnati, OH USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [21] Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring
    Reine, Pal A.
    Vethe, Nils T.
    Kongsgaard, Ulf E.
    Andersen, Anders M.
    Line, Pal D.
    Ali, Ali M.
    Bergan, Stein
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2013, 73 (02): : 117 - 124
  • [22] Inosine Monophosphate Dehydrogenase Messenger RNA Expression Is Correlated to Clinical Outcomes in Mycophenolate Mofetil-Treated Kidney Transplant Patients, Whereas Inosine Monophosphate Dehydrogenase Activity Is Not
    Sombogaard, Ferdi
    Peeters, Annemiek M. A.
    Baan, Carla C.
    Mathot, Ron A. A.
    Quaedackers, Monique E.
    Vulto, Arnold G.
    Weimar, Willem
    van Gelder, Teun
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 549 - 556
  • [23] Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: Potential clinical implications
    Weimert, Nicole A.
    DeRotte, Maurits
    Alloway, Rita R.
    Woodle, E. Steve
    Vinks, Alexander A.
    THERAPEUTIC DRUG MONITORING, 2007, 29 (02) : 141 - 149
  • [24] Ace Activity and Its Expression as a Hypertension Biomarker in the Urine of Pediatric Renal Transplant Recipients.
    Pignatari, Maria Cecilia
    Ronchi, Fernanda Aparecida
    Ribeiro, Amanda Aparecida
    Carvalhaes, Joao Tomas de Abreu
    Miranda, Larissa
    Nogueira, Paulo Cesar Koch
    Casarini, Dulce Elena
    HYPERTENSION, 2018, 72
  • [25] Effect of mycophenolic acid glucuronide an inosine monophosphate dehydrogenase activity
    Nowak, I
    Shaw, LM
    THERAPEUTIC DRUG MONITORING, 1997, 19 (03) : 358 - 360
  • [26] Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment
    Vethe, NT
    Mandla, R
    Line, PD
    Midtvedt, K
    Hartmann, A
    Bergan, S
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2006, 66 (01): : 31 - 44
  • [27] Monitoring of mycophenolic acid therapy in renal transplant patients by inosine-monophosphate-dehydrogenase (IMPDH) activity
    Sommerer, Claudia
    Mueller-Krebs, Sandra
    Schaier, Matthias
    Glander, Petra
    Schwemaer, Vedat
    Zeier, Martin
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 586 - 586
  • [28] Selection of Pneumocystis jirovecii Inosine 5′-Monophosphate Dehydrogenase Mutants in Solid Organ Transplant Recipients: Implication of Mycophenolic Acid
    Hoffmann, Claire V.
    Nevez, Gilles
    Moal, Marie-Christine
    Quinio, Dorothee
    Le Nan, Nathan
    Papon, Nicolas
    Bouchara, Jean-Philippe
    Le Meur, Yannick
    Le Gal, Solene
    JOURNAL OF FUNGI, 2021, 7 (10)
  • [29] Alemtuzumab preconditioning and tacrolimus monotherapy in pediatric kidney transplant recipients.
    Shapiro, Ron
    El Jis, Demetrius
    Tan, Henkie P.
    Tz, Michael L. Mori
    Basu, Amit
    Vats, AbhayN.
    Kayler, Liise K.
    Erkan, Elif
    McFeaters, Corde G.
    James, Gerri
    Grosso, Mary J.
    Zeevi, Adriana
    Gray, Edward A.
    Marcos, Amadeo
    Starzl, Thomas E.
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 54 - 54
  • [30] STEROID FREE IMMUNOSUPPRESSION EXPERIENCE IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS.
    Barcia, John P.
    Coyne, Bethany M.
    Kane, Bartholomew
    Kumer, Sean
    Dorn, Harry
    Brayman, Kenneth L.
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 108 - 108
12345